Rigel Pharmaceuticals
RIGL
RIGL
124 hedge funds and large institutions have $149M invested in Rigel Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 37 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 37
9% less capital invested
Capital invested by funds: $163M → $149M (-$14.5M)
Holders
124
Holding in Top 10
–
Calls
$818K
Puts
$72K
Top Buyers
| 1 | +$16.9M | |
| 2 | +$2.7M | |
| 3 | +$1.56M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1,000K |
| 5 |
Two Sigma Investments
New York
|
+$887K |
Top Sellers
| 1 | -$7.99M | |
| 2 | -$5.03M | |
| 3 | -$2.26M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$2.18M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$957K |